Total Valuation
Boston Scientific has a market cap or net worth of CHF57.88B. The enterprise value is CHF75.16K.
Market CapCHF57.88B
Enterprise ValueCHF75.16K
Share Statistics
Boston Scientific has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders0.15%
Owned by Institutions4.85%
Financial Efficiency
Boston Scientific’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.78%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)8.78%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee340.24K
Profits Per Employee49.02K
Employee Count59,000
Asset Turnover0.46
Inventory Turnover2.11
Valuation Ratios
The current PE Ratio of Boston Scientific is 20.3. Boston Scientific’s PEG ratio is 0.88.
PE Ratio20.3
PS Ratio7.03
PB Ratio5.82
Price to Fair Value5.82
Price to FCF38.59
Price to Operating Cash Flow16.46
PEG Ratio0.88
Income Statement
In the last 12 months, Boston Scientific had revenue of 20.07B and earned 2.89B in profits. Earnings per share was 1.96.
Revenue20.07B
Gross Profit13.85B
Operating Income3.97B
Pretax Income3.38B
Net Income2.89B
EBITDA5.10B
Earnings Per Share (EPS)1.96
Cash Flow
In the last 12 months, operating cash flow was 4.53B and capital expenditures -904.00M, giving a free cash flow of 3.63B billion.
Operating Cash Flow4.53B
Free Cash Flow3.63B
Free Cash Flow per Share10.00T>
Dividends & Yields
Boston Scientific pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.04
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Boston Scientific upcoming earnings date is Oct 28, 2026, Before Open (Confirmed).
Last Earnings DateJul 29, 2026
Next Earnings DateOct 28, 2026
Ex-Dividend Date―
Financial Position
Boston Scientific as a current ratio of 1.62, with Debt / Equity ratio of 50.64%
Current Ratio1.62
Quick Ratio1.08
Debt to Market Cap0.08
Net Debt to EBITDA2.03
Interest Coverage Ratio11.38
Taxes
In the past 12 months, Boston Scientific has paid 493.00M in taxes.
Income Tax493.00M
Effective Tax Rate0.15
Enterprise Valuation
Boston Scientific EV to EBITDA ratio is 29.70, with an EV/FCF ratio of 41.42.
EV to Sales7.55
EV to EBITDA29.70
EV to Free Cash Flow41.42
EV to Operating Cash Flow33.42
Balance Sheet
Boston Scientific has CHF539.00M in cash and marketable securities with CHF12.62B in debt, giving a net cash position of -CHF12.09B billion.
Cash & Marketable SecuritiesCHF539.00M
Total DebtCHF12.62B
Net Cash-CHF12.09B
Net Cash Per Share-CHF10.00T>
Tangible Book Value Per Share-CHF0.56
Margins
Gross margin is 71.16%, with operating margin of 19.78%, and net profit margin of 14.38%.
Gross Margin71.16%
Operating Margin19.78%
Pretax Margin16.86%
Net Profit Margin14.38%
EBITDA Margin25.42%
EBIT Margin18.60%
Analyst Forecast
The average price target for Boston Scientific is CHF50.55, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetCHF50.55
Price Target Upside― Upside
Analyst ConsensusStrong Buy
Analyst Count24
Revenue Growth Forecast―
EPS Growth Forecast―